1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co
XNYS: LLY

Eli Lilly Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometaboli...

Read More
974.96 -12.09 (-1.22%)
56.30% Gain from 52W Low
3.4M
XNYS Volume

XNYS 07 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Dividend
Eli Lilly has an upcoming dividend of $1.73 per share due on 15 May 2026 See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
34.2 / 100
Momentum Score
Technically Moderately Bullish
60.5 / 100
Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM
Analyst Price Target
1,207
1Yr Price target upside is 24%
29 analysts

19

S

9

W

2

O

2

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..